In humans and in animals, ketamine is used mainly as an anaesthetic. In patients with Complex Regional Pain Syndrome (CRPS), formerly known as Reflex Sympathetic Dystrophy (RSD), a crippling chronic pain syndrome, ketamine therapy has been shown to be efficient. It has also been used in the treatment of acute pain, addiction, and to treat depression experimentally. For recreational purposes, it is sometimes used. Nicknames such as ‘K’, ‘Ket’, ‘Special K’, ‘Vitamin K’, ‘Pony dust’ and others are recognised here.Learn more by visiting Ketamine Treatment For Depression
Penalties against possession
‘K’ is, legally speaking, a Class C drug. This means that for personal use it holds the least serious penalties for possession. More than 80% of the seizures of this drug were found to originate in Mexico in the United States in 2003. Much of today’s recreationally used drugs come from India.
In anesthesia, the principal usage of ‘K’ is. In children it can be used as the sole anaesthetic. It is beneficial in patients with asthma or chronic obstructive pulmonary disease ( COPD) since it suppresses respiration much less than other anaesthetics. It is used in emergency medicine for trauma-trapped patients, on the frontline and in situations where the fluid state of the patient can not be measured correctly (for example, at the scene of a traffic accident).
RSD / CRPS
A extreme, chronic , progressive pain disorder is CRPS / RSD. It has components that are autonomic, visual, dystrophic and motor (the word ‘dystrophy’ refers to muscle tissue degeneration). Over time, the pain is constant and worsens. Swelling and changes to the skin can accompany it. It can begin with an arm or a leg and spread to other parts of the body.
Techniques of Treatment
For using ‘K’ to treat CRPS / RSD, there are two separate treatment modalities. A gradual infusion of a low dose over a period of days consists of the ‘awake’ technique. This can take place as an outpatient or in a hospital. The second approach includes placing the patient into a coma that is medically induced and giving them a major bolus of the medication. This technique is not licenced for use in the United States, but is commonly used in Germany and is used in parts of Mexico as well.
‘K’ has been shown to significantly boost depression in patients who have not responded to any other medications in a limited number of trials. When used to treat the disorder, it was initially found to intensify depressive symptoms associated with CRPS / RSD. As the primary outcome variable was the treatment of pain, these findings were not formally reported.